Navigation Links
Dyadic International Reports Third Quarter 2013 Financial Results
Date:11/14/2013

eration of this facility in 2014.
  • Sanofi.  Dyadic scientists have successfully purified and delivered a target protein to Sanofi, and we are now finalizing the purification process for the second.  The Company believes that Sanofi has, or will soon begin the pre-clinical testing phase using the delivered protein.
  • In support of its new product development initiative announced in the second quarter, Dyadic is expanding its Netherlands research facility by 40%.  The expansion should be complete by the end of the fourth quarter.  To offset the additional cost, Dyadic is closing its Greensboro, NC laboratory and relocating the capabilities.  In addition, Dyadic took cost reduction actions in IT and with certain external service providers during the quarter.  The full financial impact of these cost reductions will be seen during fiscal year 2014. 

    During the quarter, Dyadic received the approval of its thirteenth patent issued in the U.S. and 54th patent worldwide.  The patent is related to methods of developing and producing a variety of fungal enzymes.  The patent addresses methods to use novel enzymes in a variety of processes, including washing of clothing, detergent processes, bio-refining, de-inking and bio-bleaching of paper and pulp, and treatment of waste streams.

    Financial Results for the Quarter Ended September 30, 2013 vs. September 30, 2012Total revenue for the third quarter increased to $3.5 million compared to $2.5 million for the third quarter last year.  The increase in total revenue as compared to the same period last year was driven by a 55% increase in product related revenue, which was offset by a $211,000 decrease in research and development revenue.

    Net product-related revenue for the third quarter increased to $3.2 million compared to $2.1 million for the third quarter last year.  The increase was attributable to newly added sales chann
    '/>"/>

    SOURCE Dyadic International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
    2. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
    3. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
    4. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
    5. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
    6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
    7. Dyadic International Reports 2012 Third Quarter Financial Results
    8. 12th U.S. Patent Issued To Dyadic International
    9. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
    10. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
    11. Dyadic International To Present At World Biofuels Markets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... , March 3, 2015  Regenicin, Inc. (OTC ... specializing in the development of and commercialization of regenerative ... and organs, announced today that it has received the ... Amarantus Bioscience Holdings, Inc. (OTC Bulletin Board: ... Agreement, Amarantus made the final payments due to Regenicin ...
    (Date:3/3/2015)... 03, 2015 HubCast® Inc. ( http://www.hubcast.com ... announced the expansion of its Global Print Supply Chain ... 850 the world’s largest cities across 75 countries globally. ... 137 countries providing global enterprises ease, speed, reach, quality, ... from online order to real-world delivery at postal address ...
    (Date:3/3/2015)... March 3, 2015  Rosa & Co. LLC, a ... and simulation research, today announced it has two posters ... for Clinical Pharmacology and Therapeutics meeting in ... Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... a poster describing a quantitative systems pharmacology approach for ...
    (Date:3/3/2015)... Corner, New Jersey (PRWEB) March 03, 2015 ... NJ, has announced today that it has acquired ... Terms of the transaction were not announced. ... consulting services to the energy sector including oil ... alternative energy, and fossil and nuclear power sectors. ...
    Breaking Biology Technology:Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3HubCast Expands Global Print Supply Chain: Launches New Product Suite 2HubCast Expands Global Print Supply Chain: Launches New Product Suite 3HubCast Expands Global Print Supply Chain: Launches New Product Suite 4Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
    ... President, Wyeth Research -, MADISON, N.J., April 30 ... R. Ruffolo, Jr., Ph.D., 58, will retire as,President, Wyeth ... will be succeeded by Mikael Dohlsten, M.D., Ph.D., ... been responsible for,all pharmaceutical research and development (R&D) for ...
    ... Today John C. Lechleiter,Ph.D., president and CEO of ... praised the,Bay State for its investment in biotechnology ... and a roadmap for ensuring the state,s significant,investment ... Massachusetts Biz/Bio,Conference, a gathering of policymakers, business leaders ...
    ... Another Top Flight Sport,s Training Institute joins ... April 30 Millennium,Biotechnologies Inc., wholly-owned subsidiary ... MBTG), announced today that SURGEX(TM) has,become the ... Training Facility, http://www.edgebasketball.com, Florida,s premier basketball ...
    Cached Biology Technology:Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement 2Lilly CEO Praises Massachusetts' Leadership in Biotech, Urges Policy Prescriptions to Help Ensure State's Investment Generates Dividends and Jobs 2Lilly CEO Praises Massachusetts' Leadership in Biotech, Urges Policy Prescriptions to Help Ensure State's Investment Generates Dividends and Jobs 3SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility 2SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility 3
    (Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
    (Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
    (Date:1/22/2015)... , Europe,s ... European Patent Office to present a video retrospective of the most ... featured: Christofer Toumazou and Sophie Wilson   ... of the Award   Starting on 22 January 2015 ...
    Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
    ... When Atlantic Richfield Co. was tasked with cleaning up a ... Hons, a Texas A&M University professor, got a call to ... soil and crop science professor, spent two years leading a ... 100 years of copper mining, mineral processing and smelting in ...
    ... have identified a new compound that could treat certain types ... step in what they hope will lead to human clinical ... dystrophy, or DMD, is a degenerative muscle disease that affects ... and cardiac muscles, severely limiting the life span of sufferers. ...
    ... is to bring experts and students together to discuss ... modeling. The objectives are to: Recognize the ... modeling codes, and tell the story lines of advancements ... establish the current state of the science/technology; and, Project ...
    Cached Biology News:Mining cleanup benefits from Texas A&M expertise 2Mining cleanup benefits from Texas A&M expertise 3New compound holds promise for treating Duchenne MD, other inherited diseases 250 Years of Watershed Modeling -- Past, Present and Future 250 Years of Watershed Modeling -- Past, Present and Future 350 Years of Watershed Modeling -- Past, Present and Future 4
    ... Rabbit polyclonal to Neuron navigator 1 ( ... Antigen: Synthetic peptide conjugated to KLH ... of Mouse Neuron navigator 1. (Note: the ... (Peptide available as ab32208 .) ...
    Mouse HAI-1 Ectodomain MAb (Clone 199732)...
    pETDuet-1 is designed for the coexpression of two target genes....
    Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb...
    Biology Products: